Endothelial cell integrin laminin receptor expression in multiple sclerosis lesions

American Journal of Pathology

Volumn 153, Issue 2, 1998, Pages 405-415

  Sobel, Raymond A ^a   Hinojoza, Julian R ^b   Maeda, Atsuko ^b   Chen, Michael ^b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; LAMININ; LAMININ RECEPTOR;

ARTICLE; BLOOD BRAIN BARRIER; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; LEUKOCYTE MIGRATION; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031830708     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65584-8     Document Type: Article

References (65)

1. Paulsson M: Basement membrane proteins: structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol 1992, 27:93-127
2. Chan BM, Kassner PD, Schiro JA, Byers HR, Kupper TS, Hemler ME: Distinct cellular functions mediated by different VLA integrin o subunit cytoplasmic domains. Cell 1992, 68:1051-1060
3. Sonnenberg A: Integrins and their ligands. Curr Top Microbiol Immunol 1993, 184:7-35
4. Clark EA, Brugge JS: Integrins and signal transduction pathways: the road taken. Science 1995, 268:233-239
5. Dejana E, Raiteri M, Resnati M, Lampugnani MG: Endothelial integrins and their role in maintaining the integrity of the vessel wall. Kidney Int 1993, 43:61-65
6. Davis GE, Camarillo CW: Regulation of endothelial cell morphogenesis by integrins, mechanical forces, and matrix guidance pathways. Exp Cell Res 1995, 216:113-123
7. Shattil SJ, Ginsberg MH: Perspective series: integrin signaling in vascular biology. J Clin Invest 1997, 100:1-5
8. Basson CT, Kocher O, Basson MC, Asis A, Madri JA: Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGFβ1 correlates with reciprocal effects on cell migration. J Cell Physiol 1992, 153:118-128
9. Defilippi P, Silengo L, Tarone G: Regulation of adhesion receptors expression in endothelial cells. Curr Top Microbiol Immunol 1993, 184:87-98
10. Sepp NT, Cornelius LA, Romani N, Li LJ, Caughman SW, Lawley TJ, Swerlick RA: Polarized expression and basic fibroblast growth factor-induced down-regulation of the α6β4 integrin complex on human microvascular endothelial cells. J Invest Dermatol 1995, 104:266-279
11. Bradley JR, Thiru S, Pober JS: Hydrogen peroxide-induced endothelial retraction is accompanied by a loss of the normal spatial organization of endothelial cell adhesion molecules. Am J Pathol 1995, 147:627-641
12. Bradley JR, Pober JS: Prolonged cytokine exposure causes a dynamic redistribution of endothelial cell adhesion molecules to intercellular junctions. Lab Invest 1996, 75:463-472
13. Petzelbauer E, Springhorn JP, Tucker AM, Madri JA: Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-β1. Am J Pathol 1996, 149:923-931
14. Hershkoviz R, Goldkorn I, Lider O: Tumour necrosis factor-α interacts with laminin and functions as a pro-adhesive cytokine. Immunology 1995, 85:125-130
15. Partridge CA, Horvath CJ, Del Vecchio PJ, Phillips PG, Malik AB: Influence of extracellular matrix in tumor necrosis factor-induced increase in endothelial permeability. Am J Physiol 1992, 263:L627-L633
16. Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, Rockenstein EM, Mucke L: Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Am J Pathol 1995, 147:53-67
17. Nikkari L, Aho H, Yli-Jama T, Larjava H, Jalkanen M, Heino J: Expression of integrin family of cell adhesion receptors in rheumatoid synovium-α6 integrin subunit in normal and hyperplastic synovial lining cell layer. Am J Pathol 1993, 142:1019-1027
18. Kagami S, Border WA, Ruoslahti E, Noble NA: Coordinated expression of β1 integrins and transforming growth factor-β-induced matrix proteins in glomerulonephritis. Lab Invest 1993, 69:68-76
19. Johnson BA, Haines GK, Harlow LA, Koch AE: Adhesion molecule expression in human synovial tissue. Arthritis Rheum 1993, 36:137-146
20. Creamer D, Allen M, Sousa A, Poston R, Barker J: Altered vascular endothelium integrin expression in psoriasis. Am J Pathol 1995, 147: 1661-1667
21. Gay D, Esiri M: Blood-brain barrier damage in acute multiple sclerosis plaques-an immunocytological study. Brain 1991, 114:557-572
22. Sobel RA: The pathology of multiple sclerosis. Symposium on Multiple Sclerosis. Edited by Antel J. Neurol Clin North America, 1995, 13: 1-21
23. Sobel RA, Mitchell ME: Fibronectin in multiple sclerosis lesions. Am J Pathol 1989, 135:161-169
24. Sobel RA, Chen M, Maeda A, Hinojoza JR: Vitronectin and integrin vitronectin receptor localization in multiple sclerosis lesions. J Neuropathol Exp Neurol 1995, 54:202-213
25. Maeda A, Sobel RA: Matrix metalloproteinases in the normal human central nervous system, microglial nodules and multiple sclerosis lesions. J Neuropathol Exp Neurol 1996, 55:300-309
26. Cossins JA, Clements JM, Ford J, Miller KM, Pigott R, Vos W, Van Der Valk P, De Groot CJDA: Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol 1997, 94:590-598
27. Kwon EE, Prineas JW: Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions: an immunohistochemical study. J Neuropathol Exp Neurol 1994, 53:625-636
28. Claudio L, Raine CS, Brosnan CF: Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol 1995, 90:228-238
29. Sobel RA: The extracellular matrix in multiple sclerosis lesions. J Neuropathol Exp Neurol 1998, 57:205-217
30. Prineas JW, McDonald WI: Demyelinating diseases. Greenfield's Neuropathology, sixth edition, Graham I, Lantos PL, eds. Oxford University Press, New York, 1997, pp 813-896
31. Hemler ME, Jacobson JG, Strominger JL: Biochemical characterization of VLA-1 and VLA-2: cell surface heterodimers on activated T cells. J Biol Chem 1985, 260:15246-15252
32. b. Br J Haematol 1989, 72:191-198
33. Wayner EA, Carter WG, Piotrowicz RS, Kunicki TJ: The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol 1988, 107: 1881-1891
34. Sonnenberg A, Janssen H, Hogervorst F, Calafat J, Hilgers J: A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody. J Biol Chem 1987, 262:10376-10383
35. v) in a human osteosarcoma cell line and is a substrate for protein kinase C. EMBO J 1989, 8:2955-2965
36. Wayner EA, Orlando RA, Cheresh DA: Integrins αvβ3 and αvβ5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J Cell Biol 1995, 113:919-929
37. Ruan C, Du X, Wan H, Hu, X, Li P: Characterization of the fibrinogen binding sites using monoclonal antibodies to human platelet membrane glycoproteins IIb/IIIa. Thromb Hemostasis 1987, 58:243 (Abstr)
38. Barsky SH, Hannah JB: Extracellular hyaline bodies are basement membrane accumulations. Am J Clin Pathol 1987, 87:455-460
39. McGeer PL, Zhu SG, Dedhar S: Immunostaining of human brain capillaries by antibodies to very late antigens. J Neuroimmunol 1990, 26:213-218
40. Rössler K, Neuchrist C, Kitz K, Scheiner O, Kraft D, Lassmann H: Expression of leukocyte adhesion molecules at the human blood-brain barrier (BBB). J Neurosci Res 1992, 31:365-374
41. Faull RJ, Kovach NL, Harlan JM, Ginsberg MH: Stimulation of integrin-mediated adhesion of T lymphocytes and monocytes: two mechanisms with divergent biological consequences. J Exp Med 1994, 179:1307-1316
42. Delwel GO, de Melker AA, Hogervorst F, Jaspars LH, Fies DLA, Kuikman I, Lindblom A, Paulsson M, Timpl R, Sonnenberg A: Distinct and overlapping ligand specificities of the α3β1 integrins: recognition of laminin isoforms. Mol Biol Cell 1994, 5:203-215
43. Koyama N, Seki J, Vergel S, Mattson EJR, Yednock T, Kovach NL, Harlan JM, Clowes AW: Regulation and function of an activation-dependent epitope of the β1 integrins in vascular cells after balloon injury in baboon arteries and in vitro. Am J Pathol 1996, 148:749-761
44. Pirila L, Heino J: Altered integrin expression in rheumatoid synovial lining type B cells: in vitro cytokine regulation of α1β1, α6β1, and αvβ5 integrins. J Rheumatol 1996, 23:1691-1698
45. Merrill JE, Benveniste EN: Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996, 19:331-338
46. Navikas V, Link H: Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 1996, 45:322-333
47. Woldemar M, Alon R, Springer TA: The C-C chemokine MCP-1 differentially modulates the avidity of β1, and β2 integrins on T lympho-cytes. Immunity 1996, 4:179-187
48. Furie MB, Randolph GJ: Chemokines and tissue injury. Am J Pathol 1995, 146:1287-1301
49. Luster AD, Greenberg SM, Leder P: The IL-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4, and inhibits endothelial cell proliferation: J Exp Med 1995, 182:219-231
50. Goodkin DE, Rudick RA, Ross JS: The use of brain magnetic resonance imaging in multiple sclerosis. Arch Neurol 1994, 51: 505-516
51. 1 induces CD81-dependent cell motility without engaging the extracellular matrix migration substrate. Mol Biol Cell 1997, 8:2253-2265
52. 3 is expressed in selected microvessels after focal cerebral ischemia. Am J Pathol 1996, 149:37-44
53. 3) in human endothelial cells. J Biol Chem 1991, 266:7638-7645
54. Conforti G, Dominguez-Jimenez, Zanetti A, Gimbrone MA, Jr, Cremona O, Marchisio PC, Dejana E: Human endothelial cells express integrin receptors on the luminal aspects of their membrane. Blood 1992, 80:437-446
55. Zanetti A, Conforti G, Hess S, Martin-Padura I, Ghibaudi E, Preissner KT, Dejana E: Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membranes. Blood 1994, 84:1116-112
56. Sobel RA Mitchell ME, Fondren G: Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 1990, 136:1309-1316
57. Cannella B, Raine CS: The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995, 37:424-435
58. Bö L, Peterson JW, Mørk S, Hoffman PA, Gallatin WM, Ransohoff RM, Trapp BD: Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the β2 integrin LFA-1 in multiple sclerosis lesions. J Neuropathol Exp Neurol 1996, 55:1060-1072
59. Lampugnani MG, Resnati M, Dejana E, Marchisio PC: The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol 1991, 112:479-490
60. Defilippi P, van Hinsbergh V, Bertolotto A, Rossino P, Silengo L, Tarone G: Differential distribution and modulation of expression of α1/β1 integrin on human endothelial cells. J Cell Biol 1991, 114:855-863
61. Esiri MM, Morris CS: Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease. 2. Non-neoplastic diseases. J Neurol Sci 1991, 101: 59-72
62. Mori S, Sternberger NH, Herman MM, Sternberger LA: Variability of laminin immunoreactivity in human autopsy brain. Histochemistry 1992, 97:237-241
63. Jucker M, Tian M, Ingram DK: Laminins in the adult and aged brain. Mol Chem Neuropathol 1996, 28:209-218
64. Bartlett MR, Underwood PA, Parish CR: Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase. Immunol Cell Biol 1995, 73:113-124
65. Harvath L, Brownson NE, Fields GB, Skubitz AP: Laminin peptides stimulate human neutrophil motility. J Immunol 1994, 152:5447-5456